Oracle (NYSE:ORCL - Get Free Report) had its target price lowered by equities research analysts at TD Cowen from $300.00 to $240.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a "buy" rating on the enterprise software provider's stock. TD Cowen's price objective suggests a potential upside of 66.70% from the stock's current price.
A number of other analysts also recently issued reports on ORCL. Guggenheim reaffirmed a "buy" rating on shares of Oracle in a research note on Thursday, July 23rd. Wedbush cut their target price on shares of Oracle from $275.00 to $240.00 and set an "outperform" rating for the company in a report on Thursday, June 11th. Barclays raised their target price on shares of Oracle from $240.00 to $250.00 and gave the company an "overweight" rating in a report on Thursday, June 11th. BTIG Research reaffirmed a "buy" rating and set a $400.00 price target on shares of Oracle in a research note on Friday, June 5th. Finally, Moffett Nathanson set a $325.00 price objective on shares of Oracle in a research report on Thursday, June 11th. Two analysts have rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Oracle has an average rating of "Moderate Buy" and a consensus price target of $262.39.
Check Out Our Latest Stock Analysis on Oracle
Oracle Stock Down 3.5%
Shares of ORCL stock opened at $143.97 on Tuesday. The company's fifty day simple moving average is $140.21 and its two-hundred day simple moving average is $160.55. Oracle has a 52 week low of $114.50 and a 52 week high of $345.72. The stock has a market cap of $414.71 billion, a P/E ratio of 24.74, a PEG ratio of 0.94 and a beta of 1.72. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 3.21.
Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings data on Wednesday, June 10th. The enterprise software provider reported $2.11 earnings per share for the quarter, beating analysts' consensus estimates of $1.96 by $0.15. The firm had revenue of $19.18 billion during the quarter, compared to analyst estimates of $19.10 billion. Oracle had a return on equity of 58.62% and a net margin of 25.37%.The business's quarterly revenue was up 20.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.70 earnings per share. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. Analysts predict that Oracle will post 6.49 EPS for the current fiscal year.
Insider Transactions at Oracle
In other Oracle news, Vice Chairman Jeffrey Henley sold 400,000 shares of the business's stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $159.16, for a total transaction of $63,664,000.00. Following the completion of the transaction, the insider owned 400,000 shares in the company, valued at $63,664,000. The trade was a 50.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 40.90% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Oracle
A number of institutional investors and hedge funds have recently modified their holdings of ORCL. Cornerstone Financial Management LLC lifted its position in shares of Oracle by 65.1% during the second quarter. Cornerstone Financial Management LLC now owns 279 shares of the enterprise software provider's stock worth $41,000 after purchasing an additional 110 shares during the last quarter. Corient Private Wealth LP boosted its stake in shares of Oracle by 7.1% during the second quarter. Corient Private Wealth LP now owns 1,282,773 shares of the enterprise software provider's stock valued at $187,991,000 after purchasing an additional 85,347 shares during the period. Formuepleje A S bought a new position in shares of Oracle in the second quarter worth about $1,358,000. Amundi grew its holdings in shares of Oracle by 1.5% in the second quarter. Amundi now owns 9,878,184 shares of the enterprise software provider's stock worth $1,447,648,000 after purchasing an additional 144,087 shares during the last quarter. Finally, Wellington Grp LLC increased its stake in Oracle by 15.1% in the 2nd quarter. Wellington Grp LLC now owns 22,036 shares of the enterprise software provider's stock worth $3,229,000 after buying an additional 2,886 shares during the period. 42.44% of the stock is owned by institutional investors.
Key Oracle News
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle reported approximately $638 billion in remaining performance obligations at fiscal 2026 year-end, up 363% year over year. The backlog exceeds the company’s roughly $430 billion market value, and management expects 12% to convert to revenue within 12 months, supporting the long-term growth outlook. Oracle Has $638 Billion of Contracted Backlog and a $430 Billion Stock
- Positive Sentiment: Oracle’s healthcare AI expansion—including tools for automated coding, dictation and chart review—could deepen its position in mission-critical healthcare workflows and increase demand for its broader cloud platform. Is Oracle Using Healthcare AI to Quietly Redefine Its Core Cloud Strategy?
- Neutral Sentiment: Oracle is expected to report earnings Tuesday, making the release a near-term catalyst. Investors will focus on cloud growth, AI-related bookings, capital expenditures and whether contracted backlog is converting into revenue. Oracle Projected to Post Earnings on Tuesday
- Negative Sentiment: Higher interest rates are weighing on technology valuations, while Oracle is trading near an important technical area after a broad retreat from last year’s highs. Microsoft, Apple and Oracle Face Rising Rate Pressure
- Negative Sentiment: Critics argue Oracle’s AI buildout requires major spending before the associated revenue arrives, potentially pressuring free cash flow and returns even with record bookings. The Bill for Oracle’s AI Build Arrived Before the Revenue
- Negative Sentiment: A prominent investor reportedly advised against buying Oracle stock, reflecting concerns that the shares may remain an underperformer despite the company’s large AI opportunity. Don’t Do It, Says Top Investor About Oracle Stock
About Oracle
(
Get Free Report)
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle's product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.